References
- Griffiths W AD. Pityriasis rubra pilaris. Clin Exp Dermatol 1980; 5: 105–12
- Miralles E S, Nunez M, De La Heras M E, et al. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol 1995; 133: 990–3
- Soeprono F F. Histologic criteria for the diagnosis of pityriasis rubra pilaris. Am J Dermatopathol 1986; 8: 227–83
- Clayton B D, Jorizzo J L, Hitchcock M G, et al. Adult pityriasis rubra pilaris: a 10-year case series. J Am Acad Dermatol 1997; 36: 959–64
- Cohen P R, Prystowsky J H. Pityriasis rubra pilaris: a review of diagnosis and treatment. J Am Acad Dermatol 1989; 20: 801–7
- Dicken C H. Treatment of classic pityriasis rubra pilaris. J Am Acad Dermatol 1994; 31: 997–9
- Winkelmann R K, Thomas J R, Randle H W. Further experience with toxic vitamin A therapy in pityriasis rubra pilaris. Cutis 1983; 31: 621–9
- Dicken C H. Isotretinoin treatment of pityriasis rubra pilaris. J Am Acad Dermatol 1987; 16: 297–301
- Borok M, Lowe N J. Pityriasis rubra pilaris: further observations of systemic retinoid therapy. J Am Acad Dermatol 1990; 22: 792–5
- Foged E, Bjerring P, Kragbelle K, et al. Histologic changes in the liver during etretinate treatment. J Am Acad Dermatol 1984; 11: 580–3
- Brown J, Perry H O. Pityriasis rubra pilaris: treatment with folic acid antagonists. Arch Dermatol 1966; 94: 636–8
- Knowles W R, Chernosky M E. Pityriasis rubra pilaris: prolonged treatment with methotrexate. Arch Dermatol 1970; 102: 603–12
- Parisch L C, Woo T H. Pityriasis rubra pilaris in Korea: treatment with methotrexate. Dermatologica 1969; 139: 399–403
- Vanderbeen E E, Ellis C N, Campbell J P, et al. Methotrexate and etretinate as concurrent therapies in severe psoriasis. Arch Dermatol 1982; 118: 660–2
- Beck H I, Foged E K. Toxic hepatitis due to combination therapy with methotrexate and etretinate. Dermatologica 1983; 167: 94–6
- Tyup E, McKie M. Combination therapy for psoriasis with methotrexate and etretinate. J Am Acad Dermatol 1986; 14: 70–3
- Blauvelt A, Nahass G T, Pardo R J, Kerdal F A. Pityriasis rubra pilaris and HIV infection. J Am Acad Dermatol 1991; 24: 703–5
- Auffret N, Quint L, Domart P, et al. Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection. J Am Acad Dermatol 1992; 27: 260–1
- Bonomo R A, Korman N, Nagashima-Whalen, et al. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS. Am J Med Sci 1997; 314: 118–21
- Pavlidakey L B, Hashimoto K, Savoy L B, et al. Stanozolol in the treatment of pityriasis rubra pilaris. Arch Dermatol 1985; 121: 546–8
- Hunter G A, Forbes I J. Treatment of pityriasis rubra pilaris with azathioprine. Br J Dermatol 1972; 87: 42–5
- Binnick S A. Pityriasis rubra pilaris responding to aminonicotinamide. Arch Dermatol 1978; 114: 1348–9
- Meyer P, Van Voorst Vader P C. Lack of effect of cyclosporin A in pityriasis rubra pilaris. Acta Derm Venereol 1989; 69: 272–5
- Van De Kerkhof P CM, Steijlen P M. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol 1994; 130: 675–8
- Yaniv R, Barzilaia A, Trau H. Pityriasis rubra pilaris exacerbated by ultraviolet B phototherapy. Dermatology 1994; 189: 313